Manu Thomas Kalathottukaren

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Venous Thromboembolism

Top Venues

Biomacromolecules

Molecular pharmaceutics

ACS applied materials & interfaces

This page only lists publications with an associated author ORCID identifier.

Publications

Srinivas Abbina, Chanel C La, Sreeparna Vappala, Manu Thomas Kalathottukaren, Usama Abbasi, Arshdeep Gill, Stephanie A Smith, Charles A Haynes, James H Morrissey, Jayachandran N Kizhakkedathu
Influence of Steric Shield on Biocompatibility and Antithrombotic Activity of Dendritic Polyphosphate Inhibitor. Molecular pharmaceutics 19 (6) (2022)
Amirhossein Mafi, Srinivas Abbina, Manu Thomas Kalathottukaren, James H Morrissey, Charles Haynes, Jayachandran N Kizhakkedathu, Jim Pfaendtner, Keng C Chou
Design of Polyphosphate Inhibitors: A Molecular Dynamics Investigation on Polyethylene Glycol-Linked Cationic Binding Groups. Biomacromolecules 19 (4) (2018)
Manu Thomas Kalathottukaren, Srinivas Abbina, Kai Yu, Rajesh A Shenoi, A Louise Creagh, Charles Haynes, Jayachandran N Kizhakkedathu
A Polymer Therapeutic Having Universal Heparin Reversal Activity: Molecular Design and Functional Mechanism. Biomacromolecules 18 (10) (2017)
Prashant Kumar, Allen Takayesu, Usama Abbasi, Manu Thomas Kalathottukaren, Srinivas Abbina, Jayachandran N Kizhakkedathu, Suzana K Straus
Antimicrobial Peptide-Polymer Conjugates with High Activity: Influence of Polymer Molecular Weight and Peptide Sequence on Antimicrobial Activity, Proteolysis, and Biocompatibility. ACS applied materials & interfaces 9 (43) (2017)
Manu Thomas Kalathottukaren, Libin Abraham, Piyushkumar R Kapopara, Benjamin F L Lai, Rajesh A Shenoi, Federico I Rosell, Edward M Conway, Edward L G Pryzdial, James H Morrissey, Charles A Haynes, Jayachandran N Kizhakkedathu
Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA. Blood 129 (10) (2016)